Correspondence| Volume 40, ISSUE 6, P560-561, September 15, 1996

Hypothalamic-pituitary-adrenal axis in schizophrenia

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Altamura AC
        • Guercetti G
        • Percudani M
        • et al.
        Dexamethasone suppression test and CAT abnormalities in schizophrenia.
        Pharmacopsychiatry. 1988; 21: 56
        • Altamura AC
        • Guercetti G
        • Percudani M
        Dexamethasone suppression test in positive and negative schizophrenia.
        Psychiatry Res. 1989; 30: 69-75
        • Altamura AC
        • Percudani M
        • Mauri MC
        Negative symptoms, DST and variability of response to neuroleptics in schizophrenia.
        Eur Neuropsychopharmacol. 1993; 3: 205-207
        • Altamura AC
        • Vita A
        • Giobbio GM
        • et al.
        Prediction of response to haloperidol in schizophrenia: Neuroendocrine, neuromorphological and clinical variables.
        Int Clin Psychopharmacol. 1994; 9: 3-7
        • Jeste D
        • Lohr JB
        Hippocampal pathologic findings in schizophrenia.
        Arch Gen Psychiatry. 1989; 46: 1019-1024
        • Lammers CH
        • Garcia-Borreguero D
        • Schmider J
        • et al.
        Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
        Biol Psychiatry. 1995; 38: 803-807
        • Newcomer JW
        • Faustman WO
        • Whiteford H
        • et al.
        Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients.
        Biol Psychiatry. 1991; 29: 855-864
        • Tandon R
        • Silk KR
        • Greden JF
        • et al.
        Positive and negative symptoms in schizophrenia and the dexamethasone suppression test.
        Biol Psychiatry. 1989; 25: 788-792
        • Tandon R
        • Mazzara C
        • DeQuardo J
        • et al.
        Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome.
        Biol Psychiatry. 1991; 29: 953-964